Search

You searched for "lesion"

395 results found

Theatre utilisation in urology theatres at a UK tertiary referral centre

1 September 2014 | | URO - Andrology, URO - Basic Science Research, URO - Endourology & Stones, URO - Infection, URO - Neurourology, URO - Paediatrics, URO - Functional / Reconstructive Urology, URO - Technology, URO - Trauma & Emergency, URO - Urologic Oncology, URO - Uroradiology
Introduction The efficient use of operating theatres is important to ensure optimum cost-benefit for the hospital and to clear waiting lists. The key elements in the efficient use of operating theatres are: effective management and good communication, trained staff, appropriate...

Medium: yet another social media platform?

1 January 2017 | | URO - Technology
A new social media platform seems to be announced on a weekly basis and it can be difficult to work out which are here to stay, and which will quickly fade. Medium is a free and open social media writing...

UROsource

1 January 2016 |
The European Association of Urology (EAU) has a new educational platform called UROsource, the learning library for urologists. The EAU library contains a searchable index of EAU conference proceedings, European Urology (EU) journals and EAU Guidelines. The searchable index is...

Urodynamics in review: stress urinary incontinence in women produced by the Urodynamics Committee of the ICS

1 November 2018 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology
Urodynamic studies (UDS) are the best tools to objectively assess the lower urinary tract dysfunction (LUTD) of various aetiologies [1]. According to the general understanding and consensus of the medical community UDS should be performed only when they will change...

A guide to percutaneous nephrolithotomy

1 July 2019 | | URO - Endourology & Stones
Percutaneous nephrolithotomy (PCNL) is now the gold standard approach to treating large renal stones. Since its development in the 1970s, it has undergone a series of refinements that could only have been possible with the symbiosis of both radiological and...

Clinical Trials 2 – key papers

1 March 2017 | URO - Basic Science Research
Clinical Trials 1 is available here. Case 1 This British study on haematuria clinic diagnostic yield was published in the British Journal of Urology International in 2006. The results are often asked in examinations! Edwards TJ, et al. A prospective...

Artificial intelligence

1 March 2019 | | URO - Technology
Artificial intelligence concerns me. Generally, people still tend to be concerned that their livelihoods will be replaced by an all powerful, all knowing artificial intelligence (AI) system. This at a time when the world’s largest technology companies (Amazon, Google, Apple),...

Still Getting It Right First Time (GIRFT) in urology: meeting the challenges presented by COVID-19

3 May 2022 |
Back in 2019, Simon Harrison – the then sole national lead for the urology workstream in the Getting It Right First Time (GIRFT) programme – wrote an article for Urology News on the GIRFT national report and how its recommendations...

All you need to know about percutaneous nephrolithotomy: supine versus prone and mini versus traditional

1 September 2014 | | URO - Endourology & Stones
Introduction Since the first percutaneous nephrolithotomy (PCNL), the technique has undergone many innovations, including modifications in positioning, miniaturisation of instruments and combination with retrograde intra-renal surgery (see Table 1 for an outline of the history of the technique). Controversy has...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

Prostate Scotland appoints digital technology leader Peter Proud as new trustee

16 December 2025
Prostate Scotland has appointed Peter Proud, Founder and CEO of Edinburgh-based digital technology company Forrit, to its Board of Trustees. Bringing more than 30 years of experience in digital transformation, data, and AI-driven innovation, Peter will support the charity’s work...

An overview of non-surgical treatment options for Peyronie’s disease

3 May 2022 |
Peyronie’s disease (PD) is a therapeutic challenge despite the availability of several non-surgical and surgical options. Very few of these options are supported by good quality evidence according to the current American and European guidelines [1-3]. The period of plaque...